Searching for Brain Shrinkage Clues in Alzheimer’s Disease
Alzheimer’s disease progression is marked by the buildup of amyloid and tau proteins, leading to neuronal loss and brain atrophy. Researchers are investigating whether regional volume loss serves as a more effective imaging biomarker for cognitive decline. A study by Meaghan Morris and colleagues at Johns Hopkins University examined shrinkage patterns in key regions—including the hippocampus, entorhinal cortex, and amygdala—using longitudinal MRI scans. While hippocampal atrophy correlated with more advanced disease, the entorhinal cortex and amygdala showed faster, more severe shrinkage and proved more predictive of early clinical symptoms. These findings suggest that targeting non-hippocampal regions could improve early detection and monitoring of Alzheimer’s-related brain changes.
The Need for Multiple Biomarkers to Identify Healthy Brain Aging Phenotypes
Aging does not always correlate with cognitive decline. Karlon Johnson and his team at the University of Miami explored why some individuals maintain cognitive health into old age while others develop Alzheimer’s pathology. By combining blood-based biomarkers—including phosphorylated tau 217, neurofilament light chain, and glial fibrillary acidic protein—with MRI-derived brain age metrics, the researchers distinguished between brain resistance (maintaining health despite pathology) and resilience (preserving function despite disease). Analysis of the McKnight Brain Aging Registry revealed that nearly half of cognitively normal participants had elevated p-tau217 levels yet showed no symptoms. Notably, some individuals exhibited a brain age up to eight years younger than their chronological age. These results indicate that blood tests and imaging capture complementary dimensions of brain health, and their integration may identify those with greater resistance or resilience to neurodegeneration.
Depression Can Affect Mitochondrial Genes
Major depressive disorder currently lacks reliable biomarkers, posing a significant barrier to targeted treatment. Maura Dupont and colleagues at Columbia University investigated gene expression across brain regions and blood samples from patients with MDD, revealing widespread alterations in mitochondrial-related genes. Approximately 15–20% of the genetic changes associated with depression were linked to mitochondrial function, with several markers appearing in both blood and brain tissue. The research team also identified 16 biological signals related to oxidative phosphorylation, the core process by which mitochondria generate energy. These findings suggest that mitochondrial dysfunction and impaired cellular energy production may play a fundamental role in depression. While not yet established as diagnostic tools, such biomarkers could help classify biological subtypes, deepen understanding of the disorder, and inform personalized therapeutic strategies.
Training AI Models to Catch Motor Abnormality Early
Subtle movement changes can serve as early warning signs of neurological disease, yet they often go unnoticed during conventional observation. Nisarg Desai and his team at Emory University developed an AI-driven pipeline to analyze motor behavior with unprecedented detail. Using rhesus macaques infected with Zika virus as a model, the researchers captured coordinated body movements from multiple angles and decomposed them into discrete “behavioral syllables.” In healthy subjects, these movements followed predictable sequences. In Zika-infected animals, the underlying grammar of movement became disrupted, revealing coordination deficits invisible to the naked eye. By mapping how individual movements organize over time, the AI tool identified early motor abnormalities that may precede clinical symptoms. The approach demonstrates potential for early detection and objective monitoring of neurological conditions, with future applications under exploration in Parkinson’s disease and autism.
Also Read
- Next-Generation Brain-Computer Interfaces Restore Real-Time Speech for Paralyzed Patients
- Consumer Watchdog Says Big Tech’s DMA Compliance Is All Show, Urges Harsher EU Penalties
- VMware Ships Two Critical Advisories as KVM Nested-Virtualization Flaw Sparks Cloud-Vendor Standoff
- Apple Launches Hiring Drive for Senior Engineer to Lead In-House AI Agent Platform

